Received: 30 March 2021
Accepted: 20 August 2021
First Online: 1 September 2021
: Ethical approval for this study was obtained from the University of British Columbia’s Office of Research Ethics (Approval number: H18–00533) and the Shanghai Mental Health Center’s Institutional Review Board (Approval number: 2018–64). All study participants provided informed consent to participate. Survey participants were required to provide informed consent prior to accessing the survey via an online consent form. Interview and focus group participants provided written informed consent prior to commencing interviews. All participants were over the age of 18 years. This study was carried out in accordance with Canada’s Tri Council Policy Statement on Ethical Conduct for Research Involving Humans and the Declaration of Helsinki.
: Not applicable.
: JKM, JL, HC, HB, XY, TY, XW, YF, YH, ZW, YX, PZ, YS, JH, LH, LY, XL, TL, YF, and JC have no competing interests. EEM has received support for patient education activities from Otsuka.RWL has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from: Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, Hansoh, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, Michael Smith Foundation for Health Research, MITACS, Myriad Neuroscience, Ontario Brain Institute, Otsuka, Pfizer, St. Jude Medical, University Health Network Foundation, and VGH-UBCH Foundation.